Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma.

NCT00367185 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT00367185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma.
Lead sponsor
University Hospital, Lille
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2000
Completion date
October 31, 2005
Enrollment
500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma